Latest Cambrex Corp (CBM) Headlines
Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:44AM CDT
Geron Corporation was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:44AM CDT
Acura Pharmaceuticals, Inc. (ACUR) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 5% on the day.
The Global API Market is Expected to Grow at a CAGR of Around 8% during 2012-2017
M2 - Tue Mar 11, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3wnnb7/global_api_market) has announced the addition of the "Global API Market Forecast to 2017" report to their offering. The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 Trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth. In this latest research study, "Global API Market Forecast to 2017", the authors identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 Billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017. For this study, the authors have analyzed the global API market from different perspectives. It has been studied at the Captive vs. Merchant level; Branded vs. Generic level and Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies. At the regional level, the authors have provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region's market is unique with exports playing a major role in regions of India and China. Each region's regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally. Companies Mentioned: - Aurobindo Pharma Limited - BASF SE - Boehringer Ingelheim GmbH - Cambrex Corporation - Cipla - Daiichi Fine Chemicals - Divis Laboratories Limited - Dr Reddy's Laboratories - Fabbrica Italiana Sintetici - Lonza - Pfizer CentreSource - Ranbaxy Laboratories - Royal DSM - Teva Active Pharmaceutical Ingredients - Zhejiang Hisun Pharmaceutical Co. Ltd. For more information visit http://www.researchandmarkets.com/research/3w...api_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
IGI, Laboratories, Inc. (IG) in Focus: Stock up 11.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:44AM CDT
IGI, Laboratories, Inc. was a big mover last session, as the company saw its shares surge nearly 12% on the day.
Aegerion Pharmaceuticals (AEGR) Soars: Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:39AM CDT
Aegerion Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 11% on the day.
Strength Seen in Ohr Pharmaceutical, Inc. (OHRP) Stock Shoots 22% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:44AM CDT
Ohr Pharmaceutical, Inc. was a big mover last session, as the company saw its shares surge 22% on the day.
Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.
Karyopharm Therapeutics, Inc. (KPTI) Catches Eye: Stock Jumps 13.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:44AM CST
Karyopharm Therapeutics, Inc. was a big mover last session, as the company saw its shares surge 14% on the day
Strength Seen in ANI Pharmaceuticals, Inc. (ANIP): Stock Soars 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:44AM CST
ANI Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge 16% on the day.
Shares of CBM Up 10.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 05, 5:32PM CST
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on January 31st, 2014 at $18.55. In approximately 1 month, Cambrex has returned 10.84% as of today's recent price of $20.56.
Isis Pharmaceuticals, Inc. (ISIS) in Focus: Stock up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:44AM CST
Isis Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge 9% on the day.
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:51AM CST
Dendreon Corp. was a big mover last session, as its shares rose nearly 15% on the day.
Mylan, Inc. (MYL) in Focus: Stock up 9.43% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 7:44AM CST
Mylan, Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day.
Dyax Corp. (DYAX) Soars: Stock Rises 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 8:39AM CST
Dyax Corp. was a big mover last session, as its shares rose nearly 7% on the day.
Cambrex Has Returned 13.6% Since SmarTrend Recommendation (CBM)
Comtex SmarTrend(R) - Wed Feb 26, 10:00AM CST
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on January 31st, 2014 at $18.55. In approximately 4 weeks, Cambrex has returned 13.58% as of today's recent price of $21.07.
Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 8:18AM CST
Oncothyreon Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day.
Strength Seen in ImmunoCellular Therapeutics, Ltd. (IMUC): Stock Soars 14.05% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:44AM CST
ImmunoCellular Therapeutics, Ltd. was a big mover last session, as the company saw its shares surge 14% on the day.
Inovio Pharmaceuticals (INO) Soars: Stock Rises 15.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:39AM CST
Inovio Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 16% on the day.
Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 7:44AM CDT
Geron Corporation was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Acura Pharmaceuticals, Inc. (ACUR) in Focus: Stock Moves 7.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:44AM CDT
Acura Pharmaceuticals, Inc. (ACUR) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Enzymotec Ltd. (ENZY) in Focus: Stock Up 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 7:44AM CDT
Enzymotec Ltd. was a big mover last session, as the company saw its shares rise a little over 5% on the day.
The Global API Market is Expected to Grow at a CAGR of Around 8% during 2012-2017
M2 - Tue Mar 11, 11:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3wnnb7/global_api_market) has announced the addition of the "Global API Market Forecast to 2017" report to their offering. The market for Active Pharmaceutical Ingredients is brimming with activities. While it is consolidating in US and EU resulting in the emergence of few big players producing specialty APIs that target high value markets, new players are entering in the mass markets of India and China. With global healthcare spending to have reached around US$ 6.4 Trillion in 2010 and a rapidly ageing population boosting the demand for pharmaceuticals, APIs represent one of the most exciting markets for growth. In this latest research study, "Global API Market Forecast to 2017", the authors identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 113 Billion in 2012, is expected to grow at a CAGR of around 8% during 2012-2017. For this study, the authors have analyzed the global API market from different perspectives. It has been studied at the Captive vs. Merchant level; Branded vs. Generic level and Synthetic vs. Biotech level. This has been done to provide a thorough and apt assessment to players who can use the research findings to support their business strategies. At the regional level, the authors have provided a thorough understanding of the merchant API markets along with their future outlook to 2017. Each region's market is unique with exports playing a major role in regions of India and China. Each region's regulatory environment has also been elaborated, while discussing various drivers and challenges, to help new entrants overcome entry barriers. The report also provides a comparative analysis of key regions highlighting labor cost and productivity; price structure with reference to manufacturing indicators of profit margins, raw materials and conversion costs; and investment incurred in plant setups. These research findings will aid international players to strategically expand their presence globally. Companies Mentioned: - Aurobindo Pharma Limited - BASF SE - Boehringer Ingelheim GmbH - Cambrex Corporation - Cipla - Daiichi Fine Chemicals - Divis Laboratories Limited - Dr Reddy's Laboratories - Fabbrica Italiana Sintetici - Lonza - Pfizer CentreSource - Ranbaxy Laboratories - Royal DSM - Teva Active Pharmaceutical Ingredients - Zhejiang Hisun Pharmaceutical Co. Ltd. For more information visit http://www.researchandmarkets.com/research/3w...api_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
IGI, Laboratories, Inc. (IG) in Focus: Stock up 11.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:44AM CDT
IGI, Laboratories, Inc. was a big mover last session, as the company saw its shares surge nearly 12% on the day.
Aegerion Pharmaceuticals (AEGR) Soars: Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 8:39AM CDT
Aegerion Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 11% on the day.
Strength Seen in Ohr Pharmaceutical, Inc. (OHRP) Stock Shoots 22% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:44AM CDT
Ohr Pharmaceutical, Inc. was a big mover last session, as the company saw its shares surge 22% on the day.
Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.
Karyopharm Therapeutics, Inc. (KPTI) Catches Eye: Stock Jumps 13.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:44AM CST
Karyopharm Therapeutics, Inc. was a big mover last session, as the company saw its shares surge 14% on the day
Strength Seen in ANI Pharmaceuticals, Inc. (ANIP): Stock Soars 15.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:44AM CST
ANI Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge 16% on the day.
Shares of CBM Up 10.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Mar 05, 5:32PM CST
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on January 31st, 2014 at $18.55. In approximately 1 month, Cambrex has returned 10.84% as of today's recent price of $20.56.
Isis Pharmaceuticals, Inc. (ISIS) in Focus: Stock up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:44AM CST
Isis Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares surge 9% on the day.
Dendreon Corp. (DNDN) Soars: Stock Rises 14.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 7:51AM CST
Dendreon Corp. was a big mover last session, as its shares rose nearly 15% on the day.
Mylan, Inc. (MYL) in Focus: Stock up 9.43% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 7:44AM CST
Mylan, Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day.
Dyax Corp. (DYAX) Soars: Stock Rises 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 8:39AM CST
Dyax Corp. was a big mover last session, as its shares rose nearly 7% on the day.
Cambrex Has Returned 13.6% Since SmarTrend Recommendation (CBM)
Comtex SmarTrend(R) - Wed Feb 26, 10:00AM CST
SmarTrend identified an Uptrend for Cambrex (NYSE:CBM) on January 31st, 2014 at $18.55. In approximately 4 weeks, Cambrex has returned 13.58% as of today's recent price of $21.07.
Oncothyreon Inc. (ONTY) in Focus: Stock up 9.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 8:18AM CST
Oncothyreon Inc. was a big mover last session, as the company saw its shares jump a little over 9% on the day.
Strength Seen in ImmunoCellular Therapeutics, Ltd. (IMUC): Stock Soars 14.05% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:44AM CST
ImmunoCellular Therapeutics, Ltd. was a big mover last session, as the company saw its shares surge 14% on the day.
Inovio Pharmaceuticals (INO) Soars: Stock Rises 15.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 8:39AM CST
Inovio Pharmaceuticals, Inc. was a big mover last session, as its shares rose nearly 16% on the day.
